Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatoblastoma × Tissue Banks × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Thoracic Diseases 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prolactinoma 1 Pituitary ACTH Hypersecretion 1 Peritoneal Diseases 1 Paraproteinemias 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Diseases 1 Neuroblastoma 1 Nervous System Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lung Neoplasms 1 Leiomyosarcoma 1 Immunoglobulin Light-chain Amyloidosis 1 Hepatoblastoma 1 HER2 Positive Advanced Gastric Cancer 1 Gigantism 1

Interventions

X-Rays 7 Specimen Handling 7 Phantoms, Imaging 7 Cisplatin 7 Carboplatin 7 Magnetic Resonance Spectroscopy 6 Cyclophosphamide 6 Nuclear Medicine Department, Hospital 5 Granulocyte Colony-Stimulating Factor 5 Biopsy 5 sodium thiosulfate 4 Vincristine 4 Melphalan 4 Etoposide 4 Doxorubicin 4 fludarabine 3 Thiotepa 3 Mesna 3 Irinotecan 3 Fluorouracil 3 Filgrastim 3 Busulfan 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 olaparib 2 larotrectinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00228683 2013-11-26

Hepatoblastoma Biology Study and Tissue Bank

Emory University

Phase NA Withdrawn

Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡